{"name":"Leti Pharma GmbH","slug":"leti-pharma-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"s.c. injection","genericName":"s.c. injection","slug":"s-c-injection","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"}]}],"pipeline":[{"name":"s.c. injection","genericName":"s.c. injection","slug":"s-c-injection","phase":"phase_3","mechanism":"This drug targets the PD-1 receptor to modulate the immune response.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNV1J1N0lvelFTYnpqUlpyamEyWEh4YWZTRXVHbFNsclVrT2dMQlFJVlBrZ3RIYXdSeFdRMU1VV1plR0RvUWpZbnd2MHhkRzExazlncXkyV1pBd0xmbGdub3hXNHhBSU0yeXJUdWs4UFlrb2s3RXd5YUhHdzZJVHpnQkdxM2NybnZkTW5HSGMwNU9fcnM?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Competitive Landscape: Key Market Leaders and Emerging Participants in the Allergy Treatment Sector - openPR.com","headline":"Competitive Landscape: Key Market Leaders and Emerging Participants in the Allergy Treatment Sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQcTVzcTIzc0pBWWZKRk5QOVBNTkEwQkwzdTk1Z2x3NDRLcmtJOVViamtXQThQX18tb3NRY1BQcEJINnRzZ01FWDhVU1RvT1ZwSGcyY0RvVUQ3cnBxdDdYVFJtSG1QaW5JdWEwLXlyYkdZeFBsNlNtRDVlUi1BaFRkcDRCNDRGUXZyblU4bkZuUWtSZmFEbmdidU9iZHRBN19C?oc=5","date":"2026-03-27","type":"pipeline","source":"openPR.com","summary":"Global Drivers Analysis: The Rapid Evolution of the Cold Allergy and Sinus Tablet Market - openPR.com","headline":"Global Drivers Analysis: The Rapid Evolution of the Cold Allergy and Sinus Tablet Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQLXd6eW1KZk16ejAtNFNFYUVacWxfd254UnJVQnBRbzRXcDNzNjZjSkpDU0RBRGlkTjQtaHNGbTVwcE9VRURhZGZqNzdlVGZSV19nZFNqdllXTXJmNExhcW9NTlVBalI2VVRVekNaNXVScVdEYUlsOUREclpzUXMxWjRIOEhPTFNfeTRndEVWNjhsN1lzYjFYWlQ5N2cwN2hDRzFYbWx0TU9Vdw?oc=5","date":"2025-12-11","type":"pipeline","source":"Medscape","summary":"Immunotherapy for Cat Allergy Shows Favorable Safety Profile - Medscape","headline":"Immunotherapy for Cat Allergy Shows Favorable Safety Profile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE05UWtVYnYtSnEwRjcwY1Fydnl4b0M5cGNhbjIwVnNuOTJmOUtkcEI3cU96X0RHaWl5dndObmFxTUYxSUtnUEFDYURTUHhURl9fRU5ILVVFN0NfRmhaelBuOXpyLTN2d282?oc=5","date":"2025-09-18","type":"trial","source":"Wiley Online Library","summary":"Subcutaneous Allergen Immunotherapy in Adults Allergic to House Dust Mites: A Phase 3 Randomized Controlled Trial - Wiley Online Library","headline":"Subcutaneous Allergen Immunotherapy in Adults Allergic to House Dust Mites: A Phase 3 Randomized Controlled Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOdzMxNXM0cGhIYkFfNXZoNmZzS2lFSXhSVzNXbHZpcHY2Umg2elZtU0xUMkd5Wlh0Zzd4cnBNaDJTLV95aXpja3JnMW5OSGxPOGFOcGpQTmJRNFJ2V0RZdHFxdDNTbGlvM3poaUJSWWJnc0JBcEV0X2s3ZnhqODRwZC1XM29fOFhwd3Z4MktrTQ?oc=5","date":"2025-09-01","type":"pipeline","source":"healthcare-in-europe.com","summary":"AI in Action: Transforming Pharma Industry with AUTOMA+ 2025 - healthcare-in-europe.com","headline":"AI in Action: Transforming Pharma Industry with AUTOMA+ 2025 - healthcare-in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE8zeVdKLUFzbnh0Qjk4cGs5aUVHMXZTM1dXZjdWQ3RYRTc3bHNSZl9jd0otd3lId205VGVmWXB5U3lDamc1WllfRGQ1cFJnS3hxaUh0MnhfZUlrMFBDWlVoQXhjSDNFUS1kNGc?oc=5","date":"2024-04-27","type":"pipeline","source":"Wiley Online Library","summary":"Polysensitisation is associated with more severe symptoms: The reality of patients with allergy - Wiley Online Library","headline":"Polysensitisation is associated with more severe symptoms: The reality of patients with allergy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5OVGt0VGZrVTI5RkQ1WHk0eEx1NkxuN3hIME4yR0podS0wTUgzWm50S3NoMGxvU1hEMTh3SW5WdEdkV3pkVEI3M29qZl9DVWN0SjRpVDNYak5ITmZrM1JxNVE1eWs0ZzFZSkE?oc=5","date":"2024-03-05","type":"pipeline","source":"Wiley Online Library","summary":"Journal of the European Academy of Dermatology and Venereology - Wiley Online Library","headline":"Journal of the European Academy of Dermatology and Venereology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOc3ltQlRtbFJuUFlKc2NWSTdSZWdxYUhyU3Z6aTFmTTBBajBsRkM4bW9sdl9fQWp5NEdXMkJUTlpnb3QxNl9fT2hrS19XVFM2ZzZ2UEEtTjZ0aG54SnA4NE5OMVhNQl9uT1lGZ3dZMTV1UlREbzMzekNVS2s2TnBqZWlaYzJhd0p6WEctV2t4WXI0SjdmN0czdjdydXpIeWhKeURMdjlocGhtUHU5?oc=5","date":"2022-08-11","type":"pipeline","source":"European Medical Journal","summary":"Reconsider the Art of Allergen Immunotherapy - European Medical Journal","headline":"Reconsider the Art of Allergen Immunotherapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1zQkZnMldwXzd2ZDh2RlhjUEltQ1EtUHloUUdrTk92T3VkT2NKanBKck5NR093YW1QSUlRakJZLUxTcjdGdmNjVURJQTBuUEtoVjg1cm9FMTFTSWNKMmtCa1NtQmFxVENuMVgzNQ?oc=5","date":"2022-01-27","type":"trial","source":"Wiley Online Library","summary":"Novel adaptive design for allergen immunotherapy clinical trials - Bonini - 2022 - Allergy - Wiley Online Library","headline":"Novel adaptive design for allergen immunotherapy clinical trials - Bonini - 2022 - Allergy","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}